
Patients & Caregivers
Multiple Myeloma Treatment Options
Bone Marrow
Transplant
Bone Marrow Transplant
In a bone marrow transplant, the patient is treated with high doses of chemotherapy. The body would normally not be able to handle such high doses because the bone marrow and other cells would be destroyed. However, after the high dose cancer treatments, the patient is "saved" with healthy new bone marrow. At times, radiation therapy, in which radiation is given to the entire body, is also used as part of the bone marrow transplant procedure.
There are two kinds of bone marrow transplants: allogeneic and autologous. In an allogeneic bone marrow transplant, the bone marrow from another person, called a donor, is used. Often, the donor is a close relative. Allogeneic transplantation is generally limited to persons less than 55 years of age. In an autologous bone marrow transplant, the person's own bone marrow cells are used. These cells are removed and preserved before the chemotherapy is given.
Patients who get this cancer treatment stay in the hospital for a while. The bone marrow given to the patient after high-dose chemotherapy has to start making enough blood cells before the patient can go home. The period right after the transplant, until the bone marrow starts growing, is when the person is most at risk for complications, such as infection and bleeding. Patients work closely with their doctors and nurses during this time.
previous section | next section ›
SEARCH OUR WEBSITES
PRODUCTS
At Novartis Oncology, we strive to provide a broad range of innovative, practical solutions and authoritative resource therapies.
PATIENT STORIES

"My sister died of breast cancer years ago. I'm a cancer survivor-because the battle is a lot different today."
- Carol Lundin
RESEARCH INNOVATION
Novartis maintains the most promising oncology drug pipeline in the industry to treat and help people around the world.
